Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing
Reexamination Certificate
2006-11-28
2006-11-28
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C514S002600, C514S04400A, C514S185000, C514S449000, C527S300000
Reexamination Certificate
active
07141540
ABSTRACT:
Amphiphilic biocompatible cyclodextrin grafted polymers comprising a hydrophobically modified cyclodextrin moiety, a linear linker and a biocompatible hydrophilic polymer backbone, wherein said cyclodextrin moiety is grafted to said biocompatible hydrophilic polymer backbone by said linker are disclosed. The cyclodextrin-grafted biocompatible polymers of this invention may be used as bioactive agent carriers. Methods of making and using such cyclodextrin-grafted biocompatible polymers are disclosed.
REFERENCES:
patent: 4869904 (1989-09-01), Uekama et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5376645 (1994-12-01), Stella et al.
patent: 5403898 (1995-04-01), Bradshaw et al.
patent: 5473055 (1995-12-01), Mongelli et al.
patent: 5569720 (1996-10-01), Mongelli et al.
patent: 5624940 (1997-04-01), Bryant et al.
patent: 5633368 (1997-05-01), Hirsenkorn
patent: 5654422 (1997-08-01), Hirsenkorn
patent: 5874418 (1999-02-01), Stella et al.
patent: 5904929 (1999-05-01), Uekama et al.
patent: 5916883 (1999-06-01), Shalaby et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6048736 (2000-04-01), Kosak
patent: 6133248 (2000-10-01), Stella
patent: 2001/0021703 (2001-09-01), Kosak
patent: 2001/0034333 (2001-10-01), Kosak
patent: 0730869 (1996-09-01), None
patent: PCT/FR00/00377 (2000-02-01), None
patent: WO 00/01734 (2000-01-01), None
patent: WO 00/47630 (2000-08-01), None
patent: WO 04/22099 (2004-03-01), None
S.H. Hwang, N.C. Bellocq & M.E. Davis “Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery,”Bioconjug. Chem., Mar.-Apr. 2001; 12(2):280-90.
Hector Gonzales, Sue Jean Hwang and M.E. Davis, “New Class of Polymers for the Delivery of Macromolecular Therapeutics,”Biogonjug. Chem., Nov.-Dec. 1999,; 10(6):1068-74.
Kouzou Miyake, Fumitoshi Hirayama & Kaneto Ueckama, “Solubility and Mass and Nuclear Magnetic Resonance Spectroscopic Studies on Interaction of Cyclosporin A With Dimethyl-α- and -β-Cyclodextrins in Aqueous Solution,”Journal of Pharmaceutical Sciences, vol. 88, No. 1, Jan. 1999, pp. 39-45.
Benito Casu, Mario Reggiani, “Methylated Cycloamyloses (Cyclodextrins) and Their Inclusion Properties,”Carbohydr. Res., 76, 59-66 (1979).
Alan P. Croft & Richard A. Bartsch, Synthesis of Chemically Modified Cyclodextrins,Tetrahedron, vol. 39, No. 9, Great Britain, pp. 1417-1474 (1983).
same as AR.
Uma S. Sharma, Sathyamangalam V. Balasubramanian & Robert M. Straubinger, “Pharmaceutical and Physical Properties of Paclitaxel (Taxol) Complexes with Cyclodextrins,”Journal of Pharmaceutical Sciences, vol. 84, No. 10, Oct. 1995, pp. 1223-1230.
M. Pechar, K. Ulbrich, V. Subr, “Poly(ethylene Glycol) Multiblock Copolymer As A Carrier of Anti-Cancer Drug Doxorubicin,”Bioconjugate Chem., 2000, Mar. Apr. 11(2): 131-9.
Arima, Hidetoshi et al., Enhancement of gene expression by polyamidoamine dendrimer conjugates with α-, β-, and γ-cyclotrines,Bioconjugate Chem. 2001, 12, 476-484, vol. 12, No. 4, Jul./Aug. 2001.
Di Blasio, Benedetto et al., Conformation for a β-cyclodextrin monosubstituted with a cyclic dipeptide,Proc. Natl. Acad. Sci. USA, vol. 89, pp. 7218-7221, Aug. 1992.
Watanabe, Junji et al., Prepoaration and characterization of poly(ethylene glocol) hydrogels cross-linked by hydrolyzable polyrotaxane, J. Biomater. Sci. Edn, vol. 11, No. 12, pp. 1333-1345, 2000.
Bibby, David C. et al., Investigation into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres, International Journal of Pharmaceutics, 180, 1999 Elsevier Science, pp. 161-168.
Ohmura, Yasushi et al., Self-assembling dendritic supramolecle of molecular nanotubes and starpolymers,Langmuir2000, 16, American Chemical Society, pp. 10278-10280.
B.Mayer, CH.Th.Kleim, I.N.Topchieva & G.Kohler,Selective Assembly of Cyclodextrins on Poly(Ethylene Oxide)-Poly(Propylene Oxide) Block Copolymers,Journal of Computer-Aided Molecular Designs, 13: 373-383, 1999.
Suzie J. Hwang, Nathalie C. Bellocq & Mark E. Davis, Effects of Structure of β-Cyclodextrin-Containing Polymers on Gene Delivery,Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125. Received Sep. 8, 2000; Revised Manuscript Received Dec. 21, 2000.
Hector Gonzalez, Sue Jean-Hwang and M.E. Davis, New Class of Polymers for the Delivery of Macromolecular Therapeutics,Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, Received Jun. 9, 1999; Revised Manuscript Received Aug. 6, 1999. Published on Web Sep. 24, 1999.
Eva Fenyvesi, Osamu Shirakur, Jozsef Szejtli & Tsuncji Nagai, Properties of Cyclodextrin Polymer as a Tabletting Aid,Chem. Pharm. Bull. 32(2) 665-669 (1984).
Josef Pitha, S.Mitchel Harman & Mary Ellen Michel, Hydrophilic Cyclodextrin Derivatives Enable Effective Oral Administration of Steroidal Hormones,Journal of Pharmaceutical Sciences/vol. 75, No. 2, Feb. 1986.
Marcella Chiari, Viviana Desperatl, Marina Cretich, Gregorio Crini, Ludovic Janus & Michel Morcellet, Vinylpyrrolidine-β-Cyclodextrin Copolymer: A Novel Chiral Selector for Capillary Electrophoresis,Electrophoresis 1999, 20, 2614-2618.
Akira Harada, Masaoki Furue & Shun-Ichi Nozakura, Cyclodextrin-Containing Polymers, vol. 9, No. 5, Sep.-Oct. 1976.
K. Uekama, M. Otagiri, T. Irie, H.Seo & M. Tsuruoka, Improvement of Dissolution and Absorption Characteristics of Phenytoin by a Water-Soluble β-Cyclodextrin-Epichlorohydrin Polymer, IJP 00774, Sep. 7, 1984.
Julianna Szeman, Haruhisa Ueda, Jozsef Szeitli, Eva Fenyvesi, Yoshiharu Machida & Tsuneji Nagai, Complexation of Several Drugs with Water-Soluble Cyclodextrin Polymer,Chem. Pharm. Bull. 35(1) 282-288 (1987).
Akira Harada, Masaoki Furue & Shun-ichi Nozakura, Inclusion of Aromatic Compounds by a β-Cyclodextrin-Epichlorohydrin Polymer,Polymer Journal, vol. 13, No. 8, pp 777-781(1981).
Akira Harada, Masaoki Furue & Shun-ichi Nozakura, Cyclodextrin-Containing Polymers. 2. Cooperative Effects in Catalysis and Binding, vol. 9, No. 5, Sep.-Oct. 1976.
Marcella Chiari, Marina Cretich, Gregorio Crini, Ludovic Janus, Michel Morcellet, Allylamine-β-Cyclodextrin Copolymer, a Novel Chiral Selector for Capillary Electrophoresis,Journal of Chromatography A, 894 (2000) 95-103.
K. Matsubara, T. Irie, K. Uekama, Controlled Release of the LHRH Agonist Buserelin Acetate from Injectable Suspensions Containing Triacetylated Cyclodextrins in an Oil Vehicle,Journal of Controlled Release 31(1994) 173-180.
Kouzou Miyake, Fumitoshi Hirayama & Kaneto Uekam, Solubility and Mass and Nuclear Magnetic Resonance Spectroscopic Studies on Interaction of Cyclosporin a with Dimethyl-α- and -β-Cyclodextrins in Aqueous Solution,Journal of Pharmaceutical Sciences/vol. 88, No. 1, Jan. 1999.
Benito Casu, Mario Reggiani & George R. Sanderson, Methylated Cycloamyloses (Cyclodextrins) and Their Inclusion Properties, Jan. 22, 1979.
Kaneto Uekama, Naoki Hirashima, Yasuhide Horiuchi, Fumitoshi Hirayama, Takanori Ijitsu & Masao Ueno, Ethylated β-Cyclodextrins as Hydrophobic Drug Carriers: Sustained Release of Diltiazem in the Rat,Journal of Pharmaceutical Sciencesvol. 76, No. 8, Aug. 1987.
Kaneto Uekama, Hidetoshi Arima, Tetsumi Irie, Kazutaka Matsubara & Takeo Kuriki, Sustained Release of Buserelin Acetate, a Luteinizing Hormone-Releasing Hormone Agonist, from an Injectable Oily Preparation Utilizing Ethylated β-Cyclodextrin,J. Pharm. Pharmacol. 1989, 41: 874 876 Communicated May 26, 1989.
Teruko Imai, Masaki Otagiri, Hazime Saito & Kaneto Uekama, Inclusion Mode of Flurbiprofen with β-Cyclodextrin and Heptakis(2,3,6-Tri-O-methyl)-β-Cyclodextrin, and Improvements of Some Pharmaceutical Properties of Flurbiprofen by Complexation,Chem. Pharm. Bull. 36(1) 354-359 (1988).
Valentino J. Stella & Roger A. Rajewski, Cyclodextrins: Their Future in Drug Formulation and De
Ruffner Duane E.
Wang Laixin
Genta Salus LLC
Kenyon & Kenyon LLP
Schnizer Richard
LandOfFree
Cyclodextrin grafted biocompatible amphilphilic polymer and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclodextrin grafted biocompatible amphilphilic polymer and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclodextrin grafted biocompatible amphilphilic polymer and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3697834